These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13681364)

  • 1. The response of hypophysectomized mice to injections of human serum containing long-acting thyroid stimulator.
    ADAMS DD; PURVES HD; SIRETT NE
    Endocrinology; 1961 Jan; 68():154-5. PubMed ID: 13681364
    [No Abstract]   [Full Text] [Related]  

  • 2. The presence of a short-acting abnormal thyroid stimulator in the blood of a thyrotoxic patient.
    ADAMS DD; PURVES HD; SIRETT NE; BEAVEN DW
    J Clin Endocrinol Metab; 1962 Jun; 22():623-6. PubMed ID: 13859305
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.
    Shishiba Y; Solomon DH; Beall GN
    Endocrinology; 1967 May; 80(5):957-61. PubMed ID: 6023563
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
    Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
    J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
    [No Abstract]   [Full Text] [Related]  

  • 7. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 8. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.
    Onaya T; Kotani M; Yamada T; Ochi Y
    J Clin Endocrinol Metab; 1973 May; 36(5):859-66. PubMed ID: 4349046
    [No Abstract]   [Full Text] [Related]  

  • 9. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction between LATS and thyroid tissue in vitro.
    Smith BR; Munro DS
    Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
    Noguchi A; Kurihara H; Ozeki Y; Sato S
    Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
    [No Abstract]   [Full Text] [Related]  

  • 16. The serum pattern of thyroid hormones in euthyroidism and hyperthyroidism.
    ARONS WL; HYDOVITZ JD
    J Clin Endocrinol Metab; 1959 May; 19(5):548-56. PubMed ID: 13654486
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1968 Mar; 28(3):325-31. PubMed ID: 5642686
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction between thyroid tissue and the long-acting thyroid stimulator.
    Kendall-Taylor P; Smith BR; Munro DS
    Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
    [No Abstract]   [Full Text] [Related]  

  • 20. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.
    McKenzie JM; Zakarija M
    J Clin Endocrinol Metab; 1976 Apr; 42(4):778-81. PubMed ID: 177449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.